| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5'-nucleotidase ecto | 0.436 | 0.885 | 2.3E-11 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2018 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 76 | 0 | 1992 | 2019 | ||||||||
|
acidic nuclear phosphoprotein 32 family member B | 0.541 | 0.731 | 0.96 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
activated leukocyte cell adhesion molecule | 0.502 | 0.808 | 0.73 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 2 | 0.579 | 0.808 | 0.97 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
adhesion G protein-coupled receptor E2 | 0.581 | 0.615 | 2.8E-28 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
adhesion G protein-coupled receptor E5 | 0.601 | 0.538 | 3.1E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
afadin, adherens junction formation factor | 0.650 | 0.462 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2002 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
phenotype | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2009 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
aminopeptidase puromycin sensitive | 0.519 | 0.808 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
angiopoietin 2 | 0.410 | 0.846 | 0.83 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
APC down-regulated 1 | 0.644 | 0.538 | 7.3E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
apoptotic chromatin condensation inducer 1 | 0.751 | 0.308 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
arrestin 3 | 0.460 | 0.846 | 0.10 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2016 | 2019 | ||||||||
|
asparaginase | 0.559 | 0.654 | 6.2E-13 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
phenotype | 0.030 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 2 | 2013 | 2015 | ||||||||
|
BAALC binder of MAP3K1 and KLF4 | 0.631 | 0.385 | 4.4E-03 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2016 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.952 | 20 | 0 | 1997 | 2020 | ||||||||
|
BCL2 like 12 | 0.606 | 0.654 | 3.8E-09 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 35 | 0 | 1990 | 2020 |